(Q81241381)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

main subject

neoadjuvant chemotherapy

1 reference

1 reference

Lisa K Dunnwald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Julie R Gralow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Georgiana K Ellis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Robert B Livingston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hannah M Linden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Thomas J Lawton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

William E Barlow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Erin K Schubert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

David A Mankoff

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

680-688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Technetium-99m MIBI single photon emission computed tomography as an indicator of prognosis for patients with lung cancer-preliminaly report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Tc-99m MIBI uptake in breast carcinoma and axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Breast carcinoma: measurement of tumor response to primary medical therapy with color Doppler flow imaging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20831

7 January 2021

Identifiers

DOI

10.1002/CNCR.20831

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15637688%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference